CSL Behring
-
CSL to Invest $1.5B in U.S. Growth Amid Restructuring and Local Layoffs
CSL, which has major operations in King of Prussia, announced plans to expand in the U.S., reports John George for…
-
CSL Laying Off 55 Vifor Employees at King of Prussia In 15 Percent Workforce Reduction
CSL is laying off 55 employees from Vifor subsidiary assigned to its King of Prussia office in a 15 percent…
-
King of Prussia’s CSL Behring Pioneers Gene Therapy Changing Hemophilia Care
King of Prussia–based CSL Behring is at the center of a medical breakthrough that’s reshaping life for people with hemophilia,…
-
Parent Company of King of Prussia-Based CSL Behring to Eliminate 3,000 Jobs Globally
CSL, the Australian biotechnology company behind CSL Behring in King of Prussia, plans to cut up to 15 percent of…
-
Seeking More Amenities, UGI Corp. Moves to New King of Prussia Building, 880 Yards West from Present Headquarters
UGI Corp., like many United States firms in the post-COVID era, is seeking to welcome employees back on site with…
-
FDA Approves CSL Behring Marketing of Hemophilia B Gene Therapy; Its $3.5M List Price Is a Record
The Food and Drug Administration has awarded King of Prussia-based CSL Behring marketing approval for Hemgenix, the first hemophilia B…
-
CSL Behring Plans to Sublease Its King of Prussia Building
CSL Behring has decided to sublease its building at 500 N. Gulph Road in King of Prussia three years after…
-
Forbes Magazine Ranks King of Prussia Global Biotech Leader Among America’s Best Employers for 2022
The annual rankings from Forbes and Statista, the world-leading statistics portal and industry ranking provider, are based on an independent…
-
Boathouse Row to Light Up for Rare Disease Day, Says King of Prussia’s CSL Behring CEO
“Our collective hope shines a light on the progress made and challenges ahead,” CSL Behring Limited CEO and Managing Director Paul…
-
CSL Behring Partners with Uplifting Athletes for Rare Disease Research and Honors Those Making an Impact
At the celebratory event, presented by global biotherapies leader CSL Behring, Uplifting Athletes awarded $180,000 in research grants to nine promising…
-
CSL Behring’s Parent Company Named One of World’s Best Employers Fourth Consecutive Year
For the fourth year in a row, CSL Limited, the parent company of King of Prussia-based CSL Behring, has been…
-
King of Prussia-based CSL Behring Provides Update on COVID-19 Vaccine, Therapy Efforts
King of Prussia-based CSL Behring provided an update earlier this week on its multiple efforts – both independent and in…
-
King of Prussia-based CSL Behring Evaluating Experimental Drug for COVID-19
A group of companies including King of Prussia-based CSL Behring are currently testing an experimental treatment for COVID-19 derived from…
-
King of Prussia-Based CSL Behring Uses AI Forecasting System to Find People with Rare Diseases
King of Prussia-based CSL Behring is using an AI forecasting system developed over the span of four months utilizing data…
-
King of Prussia’s CSL Behring Joins Forces to Develop Potential COVID-19 Therapy
King of Prussia-based CSL Behring has joined forces with several other biopharmaceutical companies to develop a potential plasma-derived therapy to…
-
MONTCO Careers – CSL Behring
Headquartered in King of Prussia, CSL Behring, a company with 26,000+ employees in 30 countries, is a global biotechnology leader…
-
Makeover inspires new name for King of Prussia business park – Moore Park KOP
After 60 years, the King of Prussia business park has been rechristened with a name that evokes vitality, while maintaining…
-
New CPR training adopted by CSL Berhing
CSL Behring is taking its workplace wellness initiatives to a whole new level by providing the American Heart Association’s (AHA)…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
